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Abstract
Given its unique nutritional and functional advantages, human milk 
(HM) should be considered as the first choice for the nutrition of all infants, 
including preterm newborns. Since its protein, mineral and energy contents 
are not suitable to meet the high needs of very-low-birth-weight (VLBW) 
infants, HM should be fortified for these components. Fortification of HM 
is an important nutritional intervention in order to provide appropriate 
nutritional intake and appropriate growth. The standard fortification strategy 
has yielded inadequate protein intakes, resulting in slower growth as 
compared to preterm formulas. Improvement of outcomes depends on new 
fortification strategies, considering the large variability of HM composition. 
Individualized fortification, either targeted or adjustable, has been shown to 
be effective and practical in attaining adequate protein intakes and growth.
Most commercially available multi-nutrient fortifiers and protein 
concentrates are derived from bovine milk (BM), which has a protein 
composition very different from that of HM. The use of BM proteins has been 
recently questioned for possible association with intestinal inflammation in 
VLBW infants. Recently, one HM-based fortifier was shown to be associated 
with lower necrotizing enterocolitis rates and lower mortality in extremely 
premature infants, compared to BM-based products. Other milk sources are 
currently under evaluation: a randomized, controlled, single-blind clinical trial, 
coordinated by the Neonatal Unit of the University of Turin in collaboration 
with the Italian National Research Council of Turin and the University of 
Cagliari, is being carried out to evaluate the adequacy of fortifiers derived 
from donkey milk for the nutrition of preterm infants.
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The importance of an adequate nutrition for the 
preterm infant
Early postnatal growth failure due to inadequate 
nutrient intakes is still very common in very-low-
birth-weight (VLBW) infants [1-4]. Early postnatal 
period corresponds to a critical window for brain 
development, during which undernutrition can 
have permanent effects on the development of the 
central nervous system [5-6]. Clinical trials with 
preterm infants indicate that nutritional quality 
and growth in the early postnatal period have an 
important impact on the long-term neurological 
and cognitive performance [7-11]. Thus, provision 
of optimal nutrition in Neonatal Intensive Care 
Units, particularly for VLBW infants, has become 
a priority. The goal of nutritional management is 
to ensure that intakes meet needs; however, this 
is not so simple with the preterm infants. During 
early life of the preterm infants, deficit of nutrients, 
particularly proteins, occurs, due to delays in 
establishing and maintaining adequate nutritional 
intakes [1-4]. This deficit is difficult to recover 
during the unstable phase. At this point, feeding 
clinically stable preterm infant becomes crucial 
to replace the accumulated deficit, and to prevent 
morbidities related to postnatal growth failure.
Human milk (HM) has an essential role in the 
nutrition of preterm infants due to its bioactive 
and immunomodulatory components [12-14]. 
Recent evidence shows that preterm infants fed 
HM have lower rates of infection and necrotizing 
enterocolitis (NEC) [15-19] and improved neuro- 
developmental outcomes [9, 20-24] compared to 
infants fed preterm formula. The Vermont Oxford 
Network declared that, among efforts to reduce the 
nosocomial bacteremia for VLBW infants, early 
feeding with HM should have the highest priority 
[25]. The American Academy of Pediatrics strongly 
recommends HM use for preterm infants, because of 
its unique advantages with respect to host protection 
and improved developmental outcomes [26].
Fortification of human milk
Given its unique advantages, HM should be 
considered as the first choice for the nutrition of 
preterm infants. But, since the protein, mineral and 
energy content of HM is not suitable to meet the high 
needs of VLBW infants, it should be fortified [27-
29]. The awareness of the need of HM fortification 
is largely based on studies comparing “intrauterine 
nutrient intake and intrauterine growth” with the 
composition of HM and postnatal growth [1, 27]. 
Therefore, the nutritional goal is to support growth 
that “approximates the in utero growth of a normal 
foetus”. Minimum and maximum protein and energy 
intakes for VLBW infants were recommended by 
a consensus group [30] and an Expert Panel of the 
Life Sciences Research Office of the American 
Society for Nutritional Sciences [31].
The HM nutrient content provides insufficient 
quantities of protein, sodium, phosphate and 
calcium, magnesium, copper, zinc and many 
vitamins (B2, B6, C, D, E, K, folic acid) to meet 
the estimated needs of the preterm infant [31]. 
Large fluid volumes should be required to provide 
sufficient calories to maintain adequate growth. 
The composition of HM varies within a single 
feed, among feeds, and throughout the course of 
lactation. By the end of the first month of lactation, 
the protein content of preterm milk is inadequate 
to meet the needs of most preterm infants [32-34], 
so that serum albumin and blood urea nitrogen 
concentrations may decline in premature infants as 
a result of inadequate dietary protein intake [35, 
36]. Preterm infants fed unsupplemented HM can 
develop poor radiological bone mineralization, 
rickets, and fractures at 4-5 months of age, due 
to inadequate dietary intakes of calcium and 
phosphate and consequent osteopenia [37]. Other 
metabolic complications associated with the 
long-term use of unsupplemented HM in preterm 
infants include hyponatremia at 4 to 5 weeks [38], 
hypoproteinemia at 8 to 12 weeks [39], and zinc 
deficiency at 2 to 6 months [40].
Now, food-industry produced multicomponent 
fortifiers are available to supplement HM. Most 
of the available fortifiers contain varying amounts 
of protein, carbohydrate, calcium, phosphate, 
other minerals (zinc, manganese, magnesium, and 
copper), vitamins, and electrolytes.
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Strategies for human milk fortification
The main factor responsible for limited success 
with HM fortification is that standard fortification 
strategy is based on routine assumptions about the 
composition of HM: the common practice is to 
add a fix amount of fortifier, assuming that HM 
has an average protein content and the infant has 
an average protein requirement. But the protein 
concentration of preterm milk is variable and 
decreases with the duration of lactation [33, 34]. 
Also, the protein concentration of banked donor 
milk, which is most often provided by mothers 
of term infants, is likely to be lower [41, 42]. 
Hence, most HM fed to preterm infants during the 
fortification period is likely to have an inadequately 
low protein concentration [4, 36]. Actual protein 
intakes are consistently and significantly lower 
than we assume when we fortify in standard 
fashion.
Novel fortification strategies should deal with 
the problem of ongoing protein undernutrition. 
Individualized fortification approach appears to 
be promising for the optimization of fortification 
methods [43-45]. Individualized fortification is 
now believed to be the best solution to the problem 
of variability of the composition of HM and donor 
HM. Currently, there are two proposed methods for 
individualization: the first, targeted fortification, 
depends on milk analyses; the second, adjustable 
fortification, depends on the metabolic response of 
each infant.
In the targeted approach, proposed by Polberger 
et al. [44], the concept is to analyze the HM and 
to fortify it in such a way that each infant always 
receives the amount of nutrient needed. The milk 
is thus analysed periodically and a target nutrient 
intake (in this case, proteins) is chosen according 
to the predefined requirements of preterm infants. 
The amount of fortifier is added considering the 
protein content of the milk to reach the targeted 
intake. The two main shortfalls of targeted 
fortification are that a milk analyser has a high 
cost, the procedures are labour intensive, and 
may not be practical for the routine use of each 
nursery, and that the quantities of protein and fat 
are relatively small, and need to be measured with 
extreme accuracy.
In the approach of adjustable fortification, 
protein intake is adjusted on the basis of the infant’s 
metabolic response, evaluated through periodic 
determinations of blood urea nitrogen (BUN) [43, 
45, 46]. Adjustable fortification method was shown 
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to be effective in providing the preterm infants with 
adequate protein intakes and appropriate growth 
approximating intrauterine intakes and growth 
[46]. The adjustable fortification does not make 
any assumptions regarding an infant’s protein 
requirements; it directly monitors the metabolic 
response taking into consideration the actual 
protein status in each infant. Moreover, it does 
not need frequent milk analyses and expensive 
equipment, and it is not labour intensive: in 
other words, it is practical for routine use in the 
nurseries. BUN determination is considered an 
excellent index for adequacy of protein intake in 
clinically stable preterm infants [45, 46].
Composition of human milk fortifiers
The optimal qualitative composition of for- 
tifiers is also a critical issue. Most commercially 
available multi-nutrient fortifiers are derived from 
bovine milk (BM), which has a different protein 
composition with respect to HM. The composition 
of currently available fortifiers based on BM is 
shown in Tab. 1. Commercial products have a 
protein fraction composition showing different 
casein to whey protein ratio, as well as different 
degree of protein hydrolysis. Since whey proteins 
are known to have a higher biological value, due to 
the higher concentration in essential aminoacids, 
these differences may have a relevant impact on the 
nutritional value of fortifiers. For this reason, some 
fortifiers contain only whey proteins as nitrogen 
source. Moreover, the degree of protein hydrolysis 
may affect its tolerability: aminoacid formulations 
should improve tolerance issues with the sensitive 
premature gastrointestinal tract, but extensive 
hydrolysis also prevents any functional effect 
of the protein fraction. Very recently, acidified 
liquid formulations for HM fortifiers were tested 
in order to ensure liquid product sterilization, but 
these tests were abandoned because of observed 
increase in clinical complications such as acidosis, 
due to preterm infant’s inability to buffer this acid 
load [47].
A similar degree of variability could be seen 
for the carbohydrate and lipid fractions. First 
generation fortifiers did not contain lipids, while 
newly available fortifiers include plant oils as 
a source of energy, in addition to maltodextrins, 
which are the most used sugar source. Lipid fraction 
may contain medium chain triglycerides (MCT), 
which are known to be more readily absorbable 
than long chain fatty acids. Carbohydrate fraction 
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Table 1. Composition of human milk fortifiers. 
M
ulticom
ponents
Protein concentrate
Nam
e (Brand)
SMA BMF 
(N
estlè)
FM85 
(N
estlè)
Enfam
il 
HMF 
(Mead 
Johnson)
Sim
ilac 
HMF  
(Abbot 
Nutrition)
Eoprotin 
(Milupa)
Aptam
il 
FMS 
(Milupa)
Nutriprem
 
(Cow & 
Gate)
Enfam
il 
HMF 
A
cidified 
Liquid 
(Mead 
Johnson)
Sim
ilac 
HMF 
A
cidified 
Liquid 
(Abbot 
Nutrition)
Sim
ilac HMF 
Concentrated 
Liquid (Abbot 
Nutrition)
Prolact 
+ H2MF 
(Prolacta)
Milte FR 
(Milte)
Beneprotein 
(N
estlè)
ULK 
Protein 
(Dietetic 
Metabolic 
Food)
Protifar 
(Danone)
Aptam
il/
Mellin PS 
(Danone)
Form
ulation
Powder
Powder
Powder
Powder
Powder
Powder
Powder
Liquid
Liquid
Liquid
Liquid
Powder
Powder
Powder
Powder
Powder
P
rotein g (N
x6.25)
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Casein:whey 
0:100
0:100
60:40
60:40
50:50
40:60
50:50
0:100
100:0
50:50
40:60 
(hum
an 
m
ilk)
0:100
0:100
0:100
80:20
50:50
Hydrolysis
No
Yes
Yes (whey)
No
Yes
Yes
Yes
Yes
Yes
No
No
No
No
No
No
Yes
C
arbohydrate g
2.4
3.3
0.4
1.8
3.5
2.8
2.9
0.5
0.5
1.5
1.5
1.1
0.0
0.1
0.0
0.0
Lactose
-
0.3
0.4
-
-
-
-
0.5
-
-
1.5
-
-
0.1
-
-
M
altodestrins
2.4
3
-
1.8
3.5
2.2
2.9
-
0.5
1.5
n/a
1.1
-
-
-
-
GOS/FOS
-
-
-
-
-
-
-
-
-
-
n/a
0.4
-
-
-
-
Lipids g
0.2
0.0
0.9
0.4
0.0
0.0
0.0
1.0
1.0
0.4
1.5
0.0
0.0
0.5
0.0
0.0
Source
Plant
-
 M
CT/soy
M
CT
-
-
-
M
CT/soy/
sunflow
er
M
CT/soy/
coconut 
M
CT
hum
an  
m
ilk
-
-
bovine  
m
ilk
-
-
Kcal
15
17
13
14
18
14
13
14
14
14
23
8
4
4
4
4
C
alcium
 m
g
90.0
75.0
81.8
117.0
63.3
86.0
78.0
52.2
52.7
60.0
85.8
46.4
3.3
5.4
15.3
6.4
P
hosphorus m
g
46.0
45.0
40.9
67.0
66.7
57.5
57.0
28.3
28.6
34.0
45.0
25.8
-
2.7
7.9
6.3
S
odium
 m
g
18.0
26.0
14.5
15.0
33.3
31.8
12.5
12.2
12.3
10.0
30.8
7.2
2.5
1.6
0
9.3
C
hloride m
g
17.0
23.0
11.8
38.0
25.0
22.7
21.7
12.6
12.7
26.0
24.2
n/a
-
0.5
1.4
0.8
P
otassium
 m
g
28.0
66.0
26.4
63.0
4.0
20.9
20.0
20.3
20.5
42.0
41.7
n/a
5.0
3.2
1.0
15.0
M
agnesium
 m
g
3.0
4.0
0.9
7.0
3.5
8.5
8.6
0.8
0.8
4.2
3.9
0.5
-
0.6
0.3
0.6
V
itam
in C
 m
g
40
18
11
25
25
18
17
7
7
15
< 0.2
n/a
n/a
n/a
n/a
n/a
Added active 
ingredients 
-
-
-
-
-
-
-
D
H
A
. A
R
A
DHA
D
H
A
. A
R
A
-
Lactoferrin
-
-
-
-
O
sm
olarity m
O
sm
/L
394  b
314  a /385  b
377
 a /401  b
385  b
371  a /394  b
343  a /436  b
400
 b
326  a
339
 a
385  b
335  b
n/a
n/a
n/a
n/a
n/a
N/a: not reported; a estimated; b literature.
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is enriched by galactoligosaccarides (GOS) and 
fructoligosaccarides (FOS) in some formulations, 
due to their prebiotic function. Carbohydrates 
and polysaccharides are primarily responsible 
for the increase in osmolarity of HM. A relevant 
increase of osmolarity secondary to the addition 
of a fortifier might lead to abdominal distension, 
reduced gastric emptying, and frequent stool, that 
may cause the interruption of fortification [48]. 
The recent Consensus Statement on Human Milk 
in Feeding Premature Infants [49] drew attention 
on routinely used BM-based fortifiers, whose 
bovine proteins might be associated with intestinal 
inflammation in extremely-low-birth-weight (ELBW) 
infants [50]. Investigation on exclusive HM diets 
(human milk-based fortifier and donor HM, if 
own mother’s milk is unavailable) have been 
carried out in recent years. Currently, one HM-
based fortifier, whose composition is reported in 
Tab. 1, is available on the market. Clinical trials 
reported that exclusive HM diet is associated 
with less NEC, less NEC requiring surgery, and 
lower mortality in ELBW infants than in those 
who receive own mother’s milk supplemented 
with BM-based products [51, 52]. Hair et al. 
[53] recently reported decreased retinopathy of 
prematurity, bronchopulmonary dysplasia, patent 
ductus arteriosus, and ventilator days in infants 
with a exclusive HM diet. Ghandehari et al. [54] 
also observed a significant reduction of the need of 
total parenteral nutrition for extremely premature 
infants fed with an exclusive HM diet, when 
compared to a standard diet of HM supplemented 
with BM fortifier and preterm formula. Further 
studies are needed to establish the real potential 
of HM-based fortifier, since the early results are 
promising. The Panel of the recent Consensus 
Statement on Human Milk in Feeding Premature 
Infants concluded: “Human milk-based fortifiers 
are available, probably are of better quality than 
cow’s milk based fortifiers, but are very expensive 
at the moment” [49]. Volumes of donor HM 
necessary to produce such fortifiers are extremely 
high, and the amounts collected by HM banks at 
the moment are not enough to satisfy the needs of 
all VLBW infants, thus posing an ethical issue.
New perspectives: donkey milk-based fortifiers 
Recently, donkey and human milk diet 
integration was shown to be associated with a 
decrease of inflammatory status and with the 
improvement of lipid and glucose metabolism in a 
murine model, when compared to a diet integration 
with BM [55]. The functional similarity of human 
and donkey milk is probably due to their closeness 
in quantitative and qualitative protein, glucidic 
and lipid fractions composition, that differ to that 
of BM [56, 57].
Based on these considerations, the Neonatal Unit 
of the University of Turin is currently coordinating 
a randomized, controlled, single-blind clinical trial 
to evaluate the use of a multi-component fortifier 
and a protein concentrate derived from donkey 
milk for the nutrition of VLBW or gestational 
age < 32 weeks infants. This trial is performed in 
collaboration with the Italian National Research 
Council of Turin and the University of Cagliari. 
Aim of the trial is to assess whether adjustable 
fortification with a multi-component supplement 
and a protein supplement, both derived from donkey 
milk, affects differently feeding tolerance and 
clinical, metabolic, neurological and auxological 
outcomes at short- and long-term, with respect to 
BM-based fortifiers.
Conclusion
Current standard fortification methods have 
yielded inadequate protein intakes resulting in 
slower growth compared to preterm formulas. 
Improvement of the outcomes depends on new 
fortification strategies and on the optimization of 
fortifiers composition. Recently, new ingredients 
are being evaluated in order to improve nutrients 
bioavailability, feeding tolerance and clinical 
outcomes.
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